v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT05566483 |
Full text link
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
william.cornwell@cuanschutz.edu |
Registration date
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
2022-10-04 |
Recruitment status
Last imported at : May 11, 2023, 8 a.m. Source : ClinicalTrials.gov |
Recruiting |
Study design
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
Single group assignment |
Masking
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
Open label |
Center
Last imported at : May 11, 2023, 8 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
Long covid |
Inclusion criteria
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
inclusion criteria: adults ≥18 years with documented history of covid-19 infection and symptoms consistent with long covid lasting >4 weeks after diagnosis. |
Exclusion criteria
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
history of cardiovascular/pulmonary disease prior to infection covid-related myocardial injury such as evidence of myocarditis deep vein thrombosis/pulmonary embolism following covid-19 infection exercise intolerance resulting from conditions that are not related to cardiorespiratory or autonomic factors (e.g. osteoarthritis or other musculoskeletal diseases); dependency of supplemental oxygen following covid infection due to cardiovascular and/or pulmonary complications following acute covid infection body mass index > 35kg/m2 age of greater than 65 years. |
Number of arms
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
University of Colorado, Denver |
Inclusion age min
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
65 |
Countries
Last imported at : May 11, 2023, 8 a.m. Source : ClinicalTrials.gov |
United States |
Type of patients
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
Patients recovered from covid |
Severity scale
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
N/A |
Total sample size
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
30 |
primary outcome
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
Characterizing the impact of exercise training (cardiac rehabilitation) on functional capacity among patients with Long COVID;Characterizing the impact of exercise training (cardiac rehabilitation) on HRqOL among patients with Long COVID |
Notes
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
Not reported |
Arms
Last imported at : Oct. 5, 2022, 7:30 a.m. Source : ClinicalTrials.gov |
[{"arm_notes": "nan", "treatment_id": 41, "treatment_name": "Aerobic exercise", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 1235, "treatment_name": "Standard oxygen", "treatment_type": "Respiratory support", "pharmacological_treatment": "Non pharmacological treatment"}] |